Literature DB >> 23470257

Mechanisms linking obesity and cancer.

Sharon M Louie1, Lindsay S Roberts, Daniel K Nomura.   

Abstract

The incidence of obesity in US adults has been steadily increasing over the past few decades. Many comorbidities associated with obesity have been well-established such as type 2 diabetes and cardiovascular diseases. However, more recently an epidemiological relationship between obesity and the prevalence of a variety of cancers has also been uncovered. The shift of the paradigm surrounding white adipose tissue function from purely an energy storage tissue, to one that has both endocrine and metabolic relevance, has led to several mechanisms implicated in how obesity drives cancer prevalence and cancer deaths. Currently, there are four categories into which these mechanisms fall - increased lipids and lipid signaling, inflammatory responses, insulin resistance, and adipokines. In this review, we examine each of these categories and the mechanisms through which they drive cancer pathogenesis. Understanding the relationship(s) between obesity and cancer and especially the nodal points of control in these cascades will be essential in developing effective therapeutics or interventions for combating this deadly combination. This article is part of a Special Issue entitled Lipid Metabolism in Cancer.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Fatty acid; Inflammation; Lipid signaling; Metabolism; Obesity

Mesh:

Substances:

Year:  2013        PMID: 23470257      PMCID: PMC3766377          DOI: 10.1016/j.bbalip.2013.02.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  177 in total

Review 1.  Childhood obesity and adult morbidities.

Authors:  Frank M Biro; Michelle Wien
Journal:  Am J Clin Nutr       Date:  2010-03-24       Impact factor: 7.045

2.  Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance.

Authors:  Giorgio Sesti; Angela Sciacqua; Marina Cardellini; Maria Adelaide Marini; Raffaele Maio; Marco Vatrano; Elena Succurro; Renato Lauro; Massimo Federici; Francesco Perticone
Journal:  Diabetes Care       Date:  2005-01       Impact factor: 19.112

3.  Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.

Authors:  Vladislava O Melnikova; Alexandra A Mourad-Zeidan; Dina Chelouche Lev; Menashe Bar-Eli
Journal:  J Biol Chem       Date:  2005-11-23       Impact factor: 5.157

4.  Platelet-activating factor and human thyroid cancer.

Authors:  Yves Denizot; Thierry Chianéa; François Labrousse; Véronique Truffinet; Manuela Delage; Muriel Mathonnet
Journal:  Eur J Endocrinol       Date:  2005-07       Impact factor: 6.664

5.  The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments.

Authors:  Miriam Cnop; Melinda J Landchild; Josep Vidal; Peter J Havel; Negar G Knowles; Darcy R Carr; Feng Wang; Rebecca L Hull; Edward J Boyko; Barbara M Retzlaff; Carolyn E Walden; Robert H Knopp; Steven E Kahn
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

6.  Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece.

Authors:  Eleni Petridou; Christos Mantzoros; Nick Dessypris; Panagiotis Koukoulomatis; Carol Addy; Zannis Voulgaris; George Chrousos; Dimitrios Trichopoulos
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

7.  G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway.

Authors:  Ming Yang; Wendy W Zhong; Neelam Srivastava; Anthony Slavin; Jianxin Yang; Timothy Hoey; Songzhu An
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-18       Impact factor: 11.205

8.  Perturbation by insulin of human breast cancer cell cycle kinetics.

Authors:  G E Gross; D H Boldt; C K Osborne
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

9.  Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice.

Authors:  Patricia M Alli; Michael L Pinn; Elizabeth M Jaffee; Jill M McFadden; Francis P Kuhajda
Journal:  Oncogene       Date:  2005-01-06       Impact factor: 9.867

10.  Circulating levels of leptin, adiposity and breast cancer risk.

Authors:  M-H Wu; Y-C Chou; W-Y Chou; G-C Hsu; C-H Chu; C-P Yu; J-C Yu; C-A Sun
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

View more
  47 in total

1.  Comment on "acute lymphoblastic leukemia and adiponcosis" by M. Bifilco and AM Malfitano.

Authors:  Saskia M F Pluijm; Marissa A den Hoed; Marry M van den Heuvel-Eibrink
Journal:  Haematologica       Date:  2015-10       Impact factor: 9.941

Review 2.  Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2015-12       Impact factor: 1.894

3.  Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells.

Authors:  Daniel I Benjamin; Daniel S Li; Wallace Lowe; Timothy Heuer; George Kemble; Daniel K Nomura
Journal:  ACS Chem Biol       Date:  2015-04-17       Impact factor: 5.100

4.  Obesity and thyroid cancer: is leptin the (only) link?

Authors:  Antonio Di Cristofano
Journal:  Endocrinology       Date:  2013-08       Impact factor: 4.736

5.  Importance of factors affecting serum leptin levels.

Authors:  Erdim Sertoglu
Journal:  World J Surg       Date:  2015-06       Impact factor: 3.352

Review 6.  Obesity and cancer: A mechanistic overview of metabolic changes in obesity that impact genetic instability.

Authors:  Pallavi Kompella; Karen M Vasquez
Journal:  Mol Carcinog       Date:  2019-06-05       Impact factor: 4.784

7.  Body mass index, calcium supplementation and risk of colorectal adenomas.

Authors:  Elizabeth L Barry; Jennifer L Lund; Daniel Westreich; Leila A Mott; Dennis J Ahnen; Gerald J Beck; Roberd M Bostick; Robert S Bresalier; Carol A Burke; Timothy R Church; Judy R Rees; Douglas J Robertson; John A Baron
Journal:  Int J Cancer       Date:  2018-10-30       Impact factor: 7.396

8.  Genetic ablation of macrohistone H2A1 leads to increased leanness, glucose tolerance and energy expenditure in mice fed a high-fat diet.

Authors:  F Sheedfar; M Vermeer; V Pazienza; J Villarroya; F Rappa; F Cappello; G Mazzoccoli; F Villarroya; H van der Molen; M H Hofker; D P Koonen; M Vinciguerra
Journal:  Int J Obes (Lond)       Date:  2014-05-21       Impact factor: 5.095

9.  Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.

Authors:  Laurence Albiges; A Ari Hakimi; Wanling Xie; Rana R McKay; Ronit Simantov; Xun Lin; Jae-Lyun Lee; Brian I Rini; Sandy Srinivas; Georg A Bjarnason; Scott Ernst; Lori A Wood; Ulka N Vaishamayan; Sun-Young Rha; Neeraj Agarwal; Takeshi Yuasa; Sumanta K Pal; Aristotelis Bamias; Emily C Zabor; Anders J Skanderup; Helena Furberg; Andre P Fay; Guillermo de Velasco; Mark A Preston; Kathryn M Wilson; Eunyoung Cho; David F McDermott; Sabina Signoretti; Daniel Y C Heng; Toni K Choueiri
Journal:  J Clin Oncol       Date:  2016-10-20       Impact factor: 44.544

Review 10.  Mechanisms underlying the association between obesity and Hodgkin lymphoma.

Authors:  Andreia Matos; Joana Marinho-Dias; Sofia Ramalheira; Maria José Oliveira; Manuel Bicho; Ricardo Ribeiro
Journal:  Tumour Biol       Date:  2016-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.